Redox
enzymes play a critical role in transforming nascent scaffolds
into structurally complex and biologically active natural products.
Alchivemycin A (AVM, 1) is a highly oxidized polycyclic
compound with potent antimicrobial activity and features a rare 2H-tetrahydro-4,6-dioxo-1,2-oxazine (TDO) ring system. The
scaffold of AVM has previously been shown to be biosynthesized by
a hybrid polyketide synthase-nonribosomal peptide synthetase (PKS-NRPS)
pathway. In this study, we present a postassembly secondary metabolic
network involving six redox enzymes that leads to AVM formation. We
characterize this complex redox network using in vivo gene deletions, in vitro biochemical assays, and
one-pot enzymatic total synthesis. Importantly, we show that an FAD-dependent
monooxygenase catalyzes oxygen insertion into an amide bond to form
the key TDO ring in AVM, an unprecedented function of flavoenzymes.
We also show that the TDO ring is essential to the antimicrobial activity
of AVM, likely through targeting the β-subunit of RNA polymerase.
As further evidence, we show that AvmK, a β-subunit of RNA synthase,
can confer self-resistance to AVM via target modification. Our findings
expand the repertoire of functions of flavoenzymes and provide insight
into antimicrobial and biocatalyst development based on AVM.